State Board of Pharmacy v. Weinstein

514 N.E.2d 1143, 33 Ohio Misc. 2d 25, 1987 Ohio Misc. LEXIS 147
CourtCourt of Common Pleas of Ohio, Hamilton County
DecidedMay 20, 1987
DocketNo. A8604873
StatusPublished
Cited by2 cases

This text of 514 N.E.2d 1143 (State Board of Pharmacy v. Weinstein) is published on Counsel Stack Legal Research, covering Court of Common Pleas of Ohio, Hamilton County primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
State Board of Pharmacy v. Weinstein, 514 N.E.2d 1143, 33 Ohio Misc. 2d 25, 1987 Ohio Misc. LEXIS 147 (Ohio Super. Ct. 1987).

Opinion

Niehaus, J.

On or about March 10, 1986, Woodrow Weinstein, R.Ph. (hereinafter “appellant”), a registered pharmacist for Elmwood Place Pharmacy (hereinafter “Elmwood”), received a notice of hearing from the Ohio State Board of Pharmacy (hereinafter “appellee”), which declared the following allegations against him personally:

“(2) Between the dates of September 7, 1983 and June 20, 1983, Elmwood Place Pharmacy, 6100 Vine Street, Cincinnati, Ohio, did receive in commerce misbranded drugs, hold and offer for sale, and sell misbranded drugs to wit: the following misbranded drugs were purchased from Tri-State Pharmaceutical, 625 N. Wayne, Cincinnati, Ohio in place of prescription vials and were dispensed to patients pursuant to written or oral prescriptions.
“DATE DRUG QUANTITY
09/07/83 Triflouperazine 10 ID
10/12/83 Spironolactone/HCTZ 1X1000
11/10/83 Spironolactone 25 mg. 1 X M
11/10/83 L-Thyroxin .1 mg. 1X M
[26]*26“DATE DRUG QUANTITY
11/16/83 Norgesic Forte ID
12/20/83 Asendin 50 1X500
02/16/84 Norgesic Forte ID
03/16/84 Norgesic Forte ID
04/19/84 Asendin 50 ID
04/29/84 Tri-Hemil 600 10X30
05/09/84 Asendin 50 ID
06/12/84 Asendin 50 2X500
07/02/84 Norgesic Forte
01/18/85 Minocin 50
01/18/85 Minocin 100 4X50
06/20/85 Carbarn 180 IX 100
06/20/85 Carbarn 60 1X100
“Such conduct is in violation of Ohio Revised Code Section 3715.64(A) and is prohibited by Section 3715.52 of the Ohio Revised Code.”

On or about March 13, 1986, appellant requested a hearing in response to appellee’s allegations. On April 24, 1986, a hearing was held at the State Pharmacy Board, 655 Front Street, Columbus, Ohio in response to appellant’s request. On June 9, 1986, ap-pellee issued an order under R.C. Chapter 119, finding appellant received, held, offered for sale and sold misbranded drugs.

Such order declared that the conduct of appellant constituted gross immorality and dishonesty in the practice of pharmacy. Appellee’s order further found the actions of appellant to be willful violations of R.C. Chapter 3715. Appellee’s order suspended appellant’s pharmacist identification card for twelve months and imposed a monetary penalty of $4,000. Appellee further declared that this twelve-month suspension would be suspended on the condition that appellant not violate any drug laws or board rules.

On June 23,1986, appellant timely appealed appellee’s order to the Hamilton County Court of Common Pleas pursuant to R.C. 119.12. Appellant’s notice of appeal declared the basis of such appeal to be the failure of appellee’s order to be supported by reliable, probative and substantial evidence and to be in accordance with law.

On June 27,1986, appellant moved the court of common pleas to order a stay of appellee’s order. At such time, the court ordered appellee’s order stayed pending a decision by the court on appellant’s appeal.

On February 3, 1987, the court of common pleas found appellee’s order not to be supported by reliable, probative and substantial evidence and not in accordance with law. This court specifically found the record upon which appellee’s order was based only “disclosed conjectural evidence, which consisted entirely of self-serving statements, unsupported by any reliable direct evidence * * This court also found there was no reliable, probative and substantial evidence on record supporting the following rulings which were made in appellee’s order:

(1) that Elmwood did purchase misbranded drugs and plastic prescription vials from Tri-State Pharmaceutical and dispensed such drugs to patients pursuant to written or oral prescriptions;

[27]*27(2) that appellant violated R.C. 3715.64(A) or 3715.52; and

(3) that appellant engaged in any conduct which would have constituted gross immorality or dishonesty in the practice of pharmacy.

Based on these findings, this court reversed appellee’s order and ordered appellee to pay costs in the instant matter.

The instant cause came to be heard on appellant’s motion for an award of attorney fees brought under R.C. 2335.39, filed February 2, 1987. This motion was filed pursuant to the findings by this court in its February 3, 1987 order which has been enumerated above. R.C. 2335.39 provides that an individual whose net worth does not exceed one million dollars at the time the appeal is filed, and who prevails as a party to an appeal involving the state, is entitled upon filing an appropriate motion to compensation for attorney fees incurred by him in connection with such appeal. Pursuant to this statutory provision, an award of attorney fees to such a prevailing, eligible party can only be denied by a court if it determines that:

(1) “the state has sustained its burden of proof that its position in initiating the matter in controversy was substantially justified or that special circumstances make an award unjust,” or

(2) “the state has sustained its burden of proof that the prevailing eligible party engaged in conduct during the course of the action or appeal that unduly and unreasonably protracted the final resolution of the matter in controversy * * *.” R.C. 2335.39 (B)(2)(a) and (b). R.C. 2335.29 (B)(2)(b) also provides such court with the discretion to reduce an otherwise merited award based on the extent of such protracted conduct.

After considering the foregoing, the entire record, memoranda filed by counsel for both parties, and the arguments of counsel, this court hereby makes the following findings and conclusions:

(1) appellant’s motion for attorney fees meets all of the requirements of R.C. 2335.39 by

(a) identifying appellant;

(b) indicating appellant is the prevailing eligible party and is entitled to receive an award of compensation for fees (he prevailed in case No. A8604873 with net worth less than one million dollars);

(c) including a statement that ap-pellee’s position in initiating the matter in controversy was not justified;

(d) indicating the amount sought ($3,371.25) as an award; and

(e) itemizing all fees sought in the requested award.

(2) Appellee failed to meet its burden of proving under R.C. 2335.39 that its position in initiating the matter in controversy was substantially justified. As this court previously stated, the record below disclosed only conjectural evidence which consisted entirely of self-serving statements. This court finds that the substantial justification language of R.C. 2335.39(B)(2) requires appellee to prove by the preponderance of the evidence that it was substantially probable that evidence in appellee’s possession would lead to a finding of a legal violation committed by appellant as stated in appellee’s notice of hearing.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Gilmore v. Ohio State Dental Board
831 N.E.2d 461 (Ohio Court of Appeals, 2005)

Cite This Page — Counsel Stack

Bluebook (online)
514 N.E.2d 1143, 33 Ohio Misc. 2d 25, 1987 Ohio Misc. LEXIS 147, Counsel Stack Legal Research, https://law.counselstack.com/opinion/state-board-of-pharmacy-v-weinstein-ohctcomplhamilt-1987.